Biological effects of cyclosporin A: A new antilymphocytic agent

Borel, J. F., Feurer, Camille, Gubler, H. U., Stähelin, H.·1976·Agents and Actions

DOI 10.1007/bf01973261

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/bf01973261

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127
pl Bl5: A cDNA Clone of the Rat mRNA Encoding Cyclophilin
DANIELSON, P. E., FORSS-PETTER, S., BROW, M. A., CALAVETTA, L., DOUGLASS, J., MILNER, R. J., & SUTCLIFFE, J. G. (1988) · DNA · doi:10.1089/dna.1988.7.261 · Cited by 1,020
Evolution of Liver Transplantation
Starzl, T. E., Iwatsuki, S., Van Thiel, D. H., Gartner, C. J., Zitelli, B. J., Malatack, J. J., Schade, R. R., Shaw, B. W., Hakala, T. R., Rosenthal, T. J., et al. (1982) · Hepatology · doi:10.1002/hep.1840020516 · Cited by 871
X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex
Griffith, J. P., Kim, J. L., Kim, E. E., Sintchak, M. D., Thomson, J. A., Fitzgibbon, M. J., Fleming, M. A., Caron, P. R., Hsiao, K., & Navia, M. A. (1995) · Cell · doi:10.1016/0092-8674(95)90439-5 · Cited by 834
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
Lichtenstein, G. R., Abreu, M. T., Cohen, R., & Tremaine, W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.048 · Cited by 417
Calcineurin inhibitors: 40 years later, can’t live without
Azzi, J. R., Sayegh, M. H., & Mallat, S. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1390055 · Cited by 337
Cyclosporin a for Psoriasis
(1979) · New England Journal of Medicine · doi:10.1056/nejm197909063011015 · Cited by 291
Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location.
Bram, R. J., Hung, D. T., Martin, P. K., Schreiber, S. L., & Crabtree, G. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4760 · Cited by 277
Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysis
Schmitt, J., Schmitt, N., & Meurer, M. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.02023.x · Cited by 265
Chemical Synthesis of Circular Proteins
Tam, J. P., & Wong, C. T. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.323568 · Cited by 172
A comprehensive review of immunosuppression used for liver transplantation
Mukherjee, S., & Mukherjee, U. (2009) · Journal of Transplantation · doi:10.1155/2009/701464 · Cited by 140
Vacuolating encephalitis in mice infected by human coronavirus OC43
Jacomy, H., & Talbot, P. J. (2003) · Virology · doi:10.1016/s0042-6822(03)00323-4 · Cited by 128
Comparative Biodistribution and Pharmacokinetic Analysis of Cyclosporine-A in the Brain upon Intranasal or Intravenous Administration in an Oil-in-Water Nanoemulsion Formulation
Yadav, S., Gattacceca, F., Panicucci, R., & Amiji, M. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5008376 · Cited by 76
Nanotechnology for delivery of natural therapeutic substances: a review
Saka, R., & Chella, N. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01103-9 · Cited by 74
From serendipity to strategy: molecular glue degraders in cancer therapeutics
Darling, S., Bajrami, I., & West, S. C. (2025) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2025.2564068 · Cited by 9
“…in the early 1990s. the founding members of these “proximity inducers” were three natural products: cyclosporin A (csA), FK506 (tacrolimus) and rapamycin. their immunosuppressive activity piqued the curiosity of a handful of researchers (Borel et al. 1976; Sawada et al. 1987; Schreiber 1991).”
Clinical Aspects of Liver Transplantation
Mangus, R. S., & Tector, A. J. (2011) · Practical Hepatic Pathology: A Diagnostic Approach · doi:10.1016/b978-0-443-06803-4.00041-1 · Cited by 1

Authors: Borel, J. F., Feurer, C., Gubler, H. U., & Stähelin, H.
Venue: Agents and Actions
Publisher: Springer Science and Business Media LLC
Published: 1976-07
Volume: 6
Issue: 4
Pages: 468-475
ISSN: 1023-3830 (ISSN-L)
0065-4299
1420-908X
DOI: 10.1007/bf01973261
OpenAlex: W2080064179
Cited by: 1,509
References: 0
FWCI: 4.59
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review